Although the holiday season is a time for indulgence, the same cannot be said for those suffering from type 2 diabetes. Here are some ways to keep blood sugar levels normal during the festive season.
It might be a challenge trying to stay healthy during the holidays, with all the rich dishes being served every place. This is especially for type 2 diabetics, who have to maintain a strict diet in order to keep blood sugar levels at bay due to the lack of insulin being produced in their body. Fortunately, Express reports expert-recommended ways to keep blood sugar levels from spiking for type 2 diabetics, or anyone looking to cut down on their sugar intake this season.
One way is to swap chocolate and sweets for dried fruit and nuts. Dried fruit has natural sugars that will not wreak havoc on your blood sugar. Dried fruit also has fiber which is good for the digestive system as well. Nuts contain protein, and combining the two can help slow down the release of sugar.
Another way is to simply use sugar sparingly, especially in drinks. Experts recommend going for half sugar - half sweetener instead to keep blood sugar levels from spiking. In the same vein, go for sugar-free cocktails or mocktails.
A third way is to simply not skip meals, especially if you are playing host or hostess to friends and family during the Christmas season. Eat a good breakfast with fiber and protein to keep blood sugar levels from dropping, at least until lunch time.
If you are playing host or hostess to family and friends during the holidays, consider adding a certain vegetable to your salads or main courses that is shown to help keep blood sugar levels in check. Express reports that brussels sprouts, under the same vegetable family as cauliflower and kale, can help maintain healthy blood sugar levels, especially for type 2 diabetics.
This is because, like its other leafy relatives, brussels sprouts are rich in fiber, which is good for the digestive system and helps regulate bowel movements which in turn, prevents constipation. Brussels sprouts also contain alpha-lipoid acid, which is an antioxidant that is known for its possible effects on both blood sugar and insulin.


Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 



